Bio-Rad Laboratories, Inc.Class A insider trading
BIOfinancial statementsForm 4 filings on EDGAR96 transactions since Nov 9, 2024
From August 12, 2026 to November 9, 2026, 0 insiders at Bio-Rad Laboratories, Inc.Class A bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an option exercise by DiVincenzo Jonathan P. on October 24, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 27, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 12, 2026 – Nov 9, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 9, 2026. Insider data through Nov 9, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
96 transactions from November 9, 2024 to November 9, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2026 | DiVincenzo Jonathan P. | President & COO | option exercise | 1,869 | $0.00 | — | 3,832 | Oct 27, 2026 |
| Oct 24, 2026 | DiVincenzo Jonathan P. | President & COO | tax withholding | 951 | $369.95 | $352K | 2,881 | Oct 27, 2026 |
| Oct 20, 2026 | Evran Sedat | EVP, Global Supply Chain | option exercise | 1,044 | $0.00 | — | 4,647 | Oct 22, 2026 |
| Oct 20, 2026 | Evran Sedat | EVP, Global Supply Chain | tax withholding | 487 | $354.50 | $173K | 4,160 | Oct 22, 2026 |
| Sep 6, 2026 | Allison Schwartz | Director | option exercise | 92 | $0.00 | — | 1,768 | Sep 9, 2026 |
| Sep 6, 2026 | Allison Schwartz | Director | tax withholding | 34 | $386.11 | $13K | 1,734 | Sep 9, 2026 |
| Sep 6, 2026 | Barry James | EVP, President, LSG | option exercise | 1,056 | $0.00 | — | 2,495 | Sep 9, 2026 |
| Sep 6, 2026 | Barry James | EVP, President, LSG | tax withholding | 470 | $386.11 | $181K | 2,025 | Sep 9, 2026 |
| Sep 6, 2026 | Evran Sedat | EVP, Global Supply Chain | option exercise | 864 | $0.00 | — | 3,880 | Sep 9, 2026 |
| Sep 6, 2026 | Evran Sedat | EVP, Global Supply Chain | tax withholding | 277 | $386.11 | $107K | 3,603 | Sep 9, 2026 |
| Sep 6, 2026 | Engelhardt Eva Anette | EVP, President, CDG | option exercise | 1,152 | $0.00 | — | 2,313 | Sep 9, 2026 |
| Sep 6, 2026 | Engelhardt Eva Anette | EVP, President, CDG | tax withholding | 485 | $386.11 | $187K | 1,828 | Sep 9, 2026 |
| Sep 6, 2026 | Enloe Courtney C | EVP, General Counsel & Sec | option exercise | 768 | $0.00 | — | 1,957 | Sep 9, 2026 |
| Sep 6, 2026 | Enloe Courtney C | EVP, General Counsel & Sec | tax withholding | 305 | $386.11 | $118K | 1,652 | Sep 9, 2026 |
| Sep 6, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | option exercise | 1,536 | $0.00 | — | 4,933 | Sep 9, 2026 |
| Sep 6, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | tax withholding | 782 | $386.11 | $302K | 4,151 | Sep 9, 2026 |
| Sep 6, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | option exercise | 3,455 | $0.00 | — | 450,873 | Sep 9, 2026 |
| Sep 6, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | tax withholding | 1,854 | $386.11 | $716K | 449,019 | Sep 9, 2026 |
| Sep 5, 2026 | Allison Schwartz | Director | option exercise | 228 | $0.00 | — | 1,758 | Sep 9, 2026 |
| Sep 5, 2026 | Allison Schwartz | Director | tax withholding | 82 | $386.11 | $32K | 1,676 | Sep 9, 2026 |
| Sep 5, 2026 | Barry James | EVP, President, LSG | option exercise | 1,027 | $0.00 | — | 1,808 | Sep 9, 2026 |
| Sep 5, 2026 | Barry James | EVP, President, LSG | tax withholding | 369 | $386.11 | $142K | 1,439 | Sep 9, 2026 |
| Sep 5, 2026 | Evran Sedat | EVP, Global Supply Chain | option exercise | 1,027 | $0.00 | — | 3,345 | Sep 9, 2026 |
| Sep 5, 2026 | Evran Sedat | EVP, Global Supply Chain | tax withholding | 329 | $386.11 | $127K | 3,016 | Sep 9, 2026 |
| Sep 5, 2026 | Engelhardt Eva Anette | EVP, President, CDG | option exercise | 1,027 | $0.00 | — | 1,530 | Sep 9, 2026 |
| Sep 5, 2026 | Engelhardt Eva Anette | EVP, President, CDG | tax withholding | 369 | $386.11 | $142K | 1,161 | Sep 9, 2026 |
| Sep 5, 2026 | DiVincenzo Jonathan P. | President & COO | option exercise | 1,712 | $0.00 | — | 2,631 | Sep 9, 2026 |
| Sep 5, 2026 | DiVincenzo Jonathan P. | President & COO | tax withholding | 668 | $386.11 | $258K | 1,963 | Sep 9, 2026 |
| Sep 5, 2026 | Enloe Courtney C | EVP, General Counsel & Sec | option exercise | 685 | $0.00 | — | 1,435 | Sep 9, 2026 |
| Sep 5, 2026 | Enloe Courtney C | EVP, General Counsel & Sec | tax withholding | 246 | $386.11 | $95K | 1,189 | Sep 9, 2026 |
| Sep 5, 2026 | Mehta Rajat | EVP, GBL Commercial Operations | option exercise | 456 | $0.00 | — | 599 | Sep 9, 2026 |
| Sep 5, 2026 | Mehta Rajat | EVP, GBL Commercial Operations | tax withholding | 233 | $386.11 | $90K | 366 | Sep 9, 2026 |
| Sep 5, 2026 | Mehta Rajat | EVP, GBL Commercial Operations | option exercise | 1,370 | $0.00 | — | 1,736 | Sep 9, 2026 |
| Sep 5, 2026 | Mehta Rajat | EVP, GBL Commercial Operations | tax withholding | 504 | $386.11 | $195K | 1,232 | Sep 9, 2026 |
| Sep 5, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | option exercise | 1,370 | $0.00 | — | 3,956 | Sep 9, 2026 |
| Sep 5, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | tax withholding | 559 | $386.11 | $216K | 3,397 | Sep 9, 2026 |
| Sep 5, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | option exercise | 4,109 | $0.00 | — | 450,294 | Sep 9, 2026 |
| Sep 5, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | tax withholding | 2,876 | $386.11 | $1M | 447,418 | Sep 9, 2026 |
| Sep 1, 2026 | Barry James | EVP, President, LSG | option exercise | 425 | $0.00 | — | 935 | Sep 3, 2026 |
| Sep 1, 2026 | Barry James | EVP, President, LSG | tax withholding | 154 | $380.96 | $59K | 781 | Sep 3, 2026 |
| Sep 1, 2026 | Allison Schwartz | Director | option exercise | 117 | $0.00 | — | 1,573 | Sep 3, 2026 |
| Sep 1, 2026 | Allison Schwartz | Director | tax withholding | 43 | $380.96 | $16K | 1,530 | Sep 3, 2026 |
| Sep 1, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | option exercise | 5,087 | $0.00 | — | 448,521 | Sep 3, 2026 |
| Sep 1, 2026 | Schwartz Norman D | Chairman & CEO, Director, 10% owner | tax withholding | 2,336 | $380.96 | $890K | 446,185 | Sep 3, 2026 |
| Jul 25, 2026 | Engelhardt Eva Anette | EVP, President, CDG | option exercise | 246 | $0.00 | — | 592 | Jul 28, 2026 |
| Jul 25, 2026 | Engelhardt Eva Anette | EVP, President, CDG | tax withholding | 89 | $314.46 | $28K | 503 | Jul 28, 2026 |
| May 11, 2026 | Engelhardt Eva Anette | EVP, President, CDG | open-market sale | 550 | $246.54 | $136K | 346 | May 13, 2026 |
| Apr 24, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | option exercise | 1,078 | $0.00 | — | 2,984 | Apr 28, 2026 |
| Apr 24, 2026 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | tax withholding | 420 | $287.84 | $121K | 2,564 | Apr 28, 2026 |
| Apr 24, 2026 | Enloe Courtney C | EVP, General Counsel & Sec | option exercise | 186 | $0.00 | — | 827 | Apr 28, 2026 |
Who the insiders are
Everyone who reported a transaction since November 9, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Engelhardt Eva Anette | EVP, President, CDG | Sep 6, 2026 | option exercise | 2,313 | — | $136K (1) | 0 of 1 |
| Barry James | EVP, President, LSG | Sep 6, 2026 | option exercise | 2,495 | — | — | — |
| Evran Sedat | EVP, Global Supply Chain | Oct 20, 2026 | option exercise | 4,647 | — | — | — |
| Allison Schwartz | Director | Sep 6, 2026 | option exercise | 1,768 | — | — | — |
| Enloe Courtney C | EVP, General Counsel & Sec | Sep 6, 2026 | option exercise | 1,957 | — | — | — |
| Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | Sep 6, 2026 | option exercise | 4,933 | — | — | — |
| Schwartz Norman D | Chairman & CEO, Director, 10% owner | Sep 6, 2026 | option exercise | 450,873 | — | — | — |
| DiVincenzo Jonathan P. | President & COO | Oct 24, 2026 | option exercise | 3,832 | — | — | — |
| Mehta Rajat | EVP, GBL Commercial Operations | Sep 5, 2026 | option exercise | 599 | — | — | — |
| Corey Colleen | EVP, Global Human Resources | Sep 6, 2025 | option exercise | 19,759 | — | — | — |
| Pei Melinda Litherland | Director | Apr 21, 2026 | option exercise | 715 | — | — | — |
| Edwards Jeffrey L | Director | Apr 21, 2026 | option exercise | 715 | — | — | — |
| Pinkston Arnold A | Director | Apr 21, 2026 | option exercise | 715 | — | — | — |
| Crowley Michael | EVP, GBL Commercial Operations | Mar 14, 2025 | option exercise | 11,171 | — | — | — |
| Hinckley Greg K | Director | Apr 21, 2026 | option exercise | 1,215 | — | — | — |
| Hinckley Gregory K | Director | Apr 22, 2025 | option exercise | 308 | — | — | — |
Questions
Are Bio-Rad Laboratories, Inc.Class A insiders buying or selling?
Over the twelve months to November 9, 2026, 1 insider at Bio-Rad Laboratories, Inc.Class A sold $136K of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $136K. Only open-market purchases and sales are counted.
Who sold the most Bio-Rad Laboratories, Inc.Class A stock in the last year?
Engelhardt Eva Anette (EVP, President, CDG) sold $136K in 1 open-market sale over the twelve months to November 9, 2026.
Do Bio-Rad Laboratories, Inc.Class A executives sell under 10b5-1 plans?
0 of the 1 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Bio-Rad Laboratories, Inc.Class A
- Bio-Rad Laboratories, Inc.Class A financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.